Published online Aug 6, 2025. doi: 10.12998/wjcc.v13.i22.104924
Revised: March 22, 2025
Accepted: April 14, 2025
Published online: August 6, 2025
Processing time: 127 Days and 23.1 Hours
Hepatic epithelioid hemangioendothelioma (HEHE) is a rare malignant vascular liver tumor diagnosed by histopathological evaluation. Standardized treatment is challenging because of its rarity; hepatectomy is preferred for solitary lesions and multiple transplantations. There is no consensus on the optimal treatment for HEHE; however, surgical excision is often considered effective. This report presents a case of initially suspected cholangiocarcinoma or renal cell carcinoma (RCC) metastasis, which was later confirmed as HEHE, with no recurrence during follow-up.
A 52-year-old man with a history of left nephrectomy for RCC presented with an incidentally detected liver mass and nonspecific abdominal discomfort. Imaging revealed a 3-cm centripetal enhancing lesion in the right hepatic dome with indeterminate malignant potential. The patient underwent a laparoscopic right anterior sectionectomy and remained recurrence-free without complications during the 3-year follow-up period.
Managing HEHE is challenging. Accurate diagnosis and surgical options, such as resection or transplantation, are essential with tailored multidisciplinary follow-up. The authors have read the CARE Checklist (2016) and the manuscript was prepared and revised according to the CARE Checklist (2016).
Core Tip: Hepatic epithelioid hemangioendothelioma (HEHE) is a rare vascular tumor often misdiagnosed as other malignancies. This case highlights the role of surgical resection not only for definitive diagnosis but also for effective management of resectable HEHE, achieving long-term recurrence-free outcomes and ensuring safe follow-up.
